Subscribe to the BioNews newsletter for free

Advanced Search

Search for

Like the Progress Educational Trust on Facebook



Mouse pancreas grown in rat reverses diabetes

30 January 2017

By Arit Udoh

Appeared in BioNews 886

Insulin-producing cells from pancreases grown in rats can cure diabetes when transplanted into mice, according to a study.

It is the first time that an interspecies organ transplant has treated a medical condition, and the mice only required a few days of immune-suppressing drugs rather than lifelong treatment.

In the study, scientists injected mouse pluripotent stem cells into rat embryos that had been genetically engineered to lack a pancreas. The rats grew pancreases that were genetically those of a mouse but contained rat blood vessels – a so-called interspecies 'chimera' organ. The researchers isolated a small number of pancreatic islet cells, which produce insulin, from the chimera organ and transplanted them into mice with diabetes.

'We found that the diabetic mice were able to normalise their blood glucose levels for over a year after the transplantation of as few as 100 of these islets,' said Professor Hiromitsu Nakauchi of Stanford University, lead author of the study, which was published in Nature.

'Furthermore, the recipient animals only needed treatment with immunosuppressive drugs for five days after transplantation, rather than the ongoing immunosuppression that would be needed for unmatched organs,' he added.

The team had previously reported growing rat pancreases in mice using a similar technique. Although the resulting mouse-derived organs were fully functional, they were much smaller than than a rat pancreas and did not produce enough islets for transplantation. By reversing the host animal from mouse to rat in this current study, Professor Nakauchi's team were able to isolate enough islets for transplantation into diabetic mice, and this successfully controlled the mice's blood sugar for over 370 days.

After 10 months, the researchers inspected the islets again and found that the mice's immune systems had eliminated all the rat cells. This is promising for the idea of growing human organs in other animals, Professor Nakauchi told Medical News Today. 'It suggests that any contaminating animal cells could be eliminated by the patient's immune system after transplant,' he said.

The researchers found no evidence of cell growth abnormalities such as tumour formation, which can often occur with pluripotent stem cells.

Type 1 diabetes occurs when the immune system attacks and destroys the body's own pancreatic islets, leaving the patient unable to produce insulin. Islet transplantation from healthy pancreases can be used to treat type 1 diabetes, but the islets cells are in short supply and recipients require immune suppression.

The study is a proof-of-principle of the viability of interspecies organ transplantation, for treating type 1 diabetes and for addressing donor organ shortages, said Professor Nakauchi.

Professor Robin Lovell-Badge of the Francis Crick Institute, who was not involved in the study, said the study was important. 'This work suggests that this technique might be a viable approach in humans if appropriate large animals can be used for chimeras... However, they need to establish these methods with a species with similar embryo development and size to humans – perhaps pigs,' he said.

Another study in Cell this week used a similar technique, transplanting human pluripotent stem cells into pig and cattle embryos (see BioNews 886).


14 August 2017 - by Cara Foley 
Ancient viral genes have been eliminated from pigs using the genome editing tool CRISPR, according to research...
07 August 2017 - by Annabel Slater 
A proof-of-concept study in mice has demonstrated how skin grafts could deliver gene therapy for obesity and diabetes...

12 September 2016 - by Dr Silvia Camporesi and Giulia Cavaliere 
By focusing all our attention on the ethics of human–animal hybrids, we may be overlooking non-technical solutions to the short supply of human organs for transplantation...
05 September 2016 - by Anneesa Amjad 
A prominent bioethicist in the USA has suggested that most of the ethical concerns surrounding the creation of animal-human chimera embryos using human pluripotent stem cells could be reasonably addressed...
08 August 2016 - by Antony Blackburn-Starza 
The US National Institutes of Health is considering lifting a ban on the funding of research to create human-animal 'chimeras' and replacing it with an ethical review process...
13 June 2016 - by Dr Jane Currie 
Scientists have used CRISPR to create part-pig, part-human embryos in an attempt to grow human organs for transplant...
18 April 2016 - by Paul Waldron 
Two new studies report the creation of functioning human beta cells, which can release insulin in response to changes in blood sugar, holding promise for the treatment of diabetes...

Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

- click here to enquire about using this story.

Published by the Progress Educational Trust


Public Conference
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation